Literature DB >> 286550

Second tumors in nonirradiated bilateral retinoblastoma.

D H Abramson, H J Ronner, R M Ellsworth.   

Abstract

We reviewed the records of 1,323 patients with retinoblastoma treated here between 1922 and 1978. Twenty-eight patients underwent bilateral enucleation alone and received no additional treatment for their advanced tumors. Of the 28 patients, 22 (92%) survived. Four patients were lost to follow-up, and two died of metastatic retinoblastoma. Of 22 survivors of bilateral retinoblastoma treated with enucleation alone, three developed second tumors at a mean of 15.3 years after bilateral enucleation. One patient developed a rhabdomyosarcoma in the left temple region, the second patient developed an osteogenic sarcoma of the right femur, and the third developed a malignant melanoma of the left thigh. All three patients died of their disease. The incidence of second tumors in patients who survived bilateral retinoblastoma treated without radiation was 14% (three patients), which is comparable to a series previously reported in which patients were treated with enucleation and irradiation.

Entities:  

Mesh:

Year:  1979        PMID: 286550     DOI: 10.1016/0002-9394(79)90293-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  14 in total

1.  Ophthaproblem. Retinoblastoma.

Authors:  S Sharma
Journal:  Can Fam Physician       Date:  1998-05       Impact factor: 3.275

2.  External beam radiation for retinoblastoma.

Authors:  D H Abramson; B Jereb; R M Ellsworth
Journal:  Bull N Y Acad Med       Date:  1981-11

3.  Alterations of the p53, Rb and MDM2 genes in osteosarcoma.

Authors:  C W Miller; A Aslo; A Won; M Tan; B Lampkin; H P Koeffler
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

4.  Retinoblastoma major review with updates on Middle East management protocols.

Authors:  Ihab Saad Othman
Journal:  Saudi J Ophthalmol       Date:  2012-04

5.  Long-term treatment effects in patients with bilateral retinoblastoma: ocular and mid-facial findings.

Authors:  E P Messmer; H Fritze; C Mohr; T Heinrich; W Sauerwein; W Havers; B Horsthemke; W Höpping
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

6.  Treatment of retinoblastoma and choroidal melanoma. A multidisciplinary approach.

Authors:  H A van Peperzeel
Journal:  Int Ophthalmol       Date:  1985-03       Impact factor: 2.031

7.  Second nonocular tumors in cured unilateral retinoblastoma patients.

Authors:  N Hausmann; F H Stefani
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

8.  Second primary tumours in hereditary- and nonhereditary retinoblastoma patients treated with megavoltage external beam irradiation.

Authors:  S M Imhof; A C Moll; P Hofman; M P Mourits; J Schipper; K E Tan
Journal:  Doc Ophthalmol       Date:  1997       Impact factor: 2.379

9.  Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen.

Authors:  S Huang; N P Wang; B Y Tseng; W H Lee; E H Lee
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

10.  The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities.

Authors:  Elizabeth Stewart; Sara Federico; Asa Karlstrom; Anang Shelat; Andras Sablauer; Alberto Pappo; Michael A Dyer
Journal:  Dev Biol       Date:  2015-06-09       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.